{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:25:42Z","timestamp":1787019942094,"version":"build-2736575974"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2017ZX09304028"],"award-info":[{"award-number":["2017ZX09304028"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81625004"],"award-info":[{"award-number":["81625004"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91742205"],"award-info":[{"award-number":["91742205"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Immunoglobulin G4-related disease (IgG4-RD) is a systemic immunoreactivity-based fibro-inflammatory disease. Immunoglobulin G4-related kidney disease (IgG4-RKD) is a frequently overlooked diagnosis. This study aimed to describe IgG4-RKD and examine the factors relevant to the renal outcomes of IgG4-RD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We studied a prospective IgG4-RKD cohort between January 2012 and December 2020 with close follow-up. Clinicopathologic data at kidney biopsy were collected and analyzed. We aimed to explore independent risk factors for long-term renal outcome and disease relapse. Patients with an eGFR&amp;lt;45 ml\/min per 1.73m<jats:sup>2<\/jats:sup> at 12 months were defined as having poor outcomes.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The included 42 patients with IgG4-RKD had a mean age of 58.5 \u00b1 8.7 years (male-to-female ratio = 5:1). The IgG4-RD responder index (RI) was 12.2 \u00b1 3.3. A total of 66.7% of the patients presented with acute on kidney disease or acute on chronic kidney disease. Eight patients (19.0%) showed nephrotic-range proteinuria, and nine (21.4%) had high-titer IgG4-autoantibodies, including antineutrophil cytoplasmic antibody and anti-phospholipase A2 receptor. A kidney biopsy was conducted in 40 patients. Thirty-seven (90.0%) patients were diagnosed with IgG4-related tubulointerstitial nephritis, and 19 (47.5%) of them had concurrent glomerular diseases (membranous nephropathy [MN], <jats:italic>n<\/jats:italic> = 3; crescentic glomerulonephritis [CrGN], <jats:italic>n<\/jats:italic> = 11; diabetic kidney disease, <jats:italic>n<\/jats:italic> = 3; and both MN and CrGN, <jats:italic>n<\/jats:italic> = 2). IgG4-RD RI had a close relationship with serum C3 (<jats:italic>R<\/jats:italic> = \u22120.509, <jats:italic>P<\/jats:italic> = 0.001), C4 (<jats:italic>R<\/jats:italic> = \u22120.314, <jats:italic>P<\/jats:italic> = 0.049) levels, and peripheral blood eosinophil count (PBEC; <jats:italic>R<\/jats:italic> = 0.377, <jats:italic>P<\/jats:italic> = 0.024), factors that were not included in RI scores. Correlation analysis disclosed that IgG4-RD RI (<jats:italic>R<\/jats:italic> = 0.422, <jats:italic>P<\/jats:italic> = 0.007), organs involved (<jats:italic>R<\/jats:italic> = 0.452, <jats:italic>P<\/jats:italic> = 0.003), and C3 (<jats:italic>R<\/jats:italic> = \u22120.487, <jats:italic>R<\/jats:italic> = 0.002) were correlated with the percentage decrease of serum creatinine at 1 month. However, multivariate regression analysis failed to identify any clinicopathological parameters that could predict short-term renal restoration and IgG4-RKD relapse. Ten out of 29 variables, of most importance, were identified by the least absolute shrinkage and selection operator (LASSO) regression analysis. By multivariate logistic regression a higher serum IgG4 (OR = 0.671, <jats:italic>P<\/jats:italic> = 0.010), IgG1 (OR = 1.396, <jats:italic>P<\/jats:italic> = 0.049), IgG3 (OR = 19.154, <jats:italic>P<\/jats:italic> = 0.039), and erythrocyte sedimentation rate (ESR; OR = 1.042, <jats:italic>P<\/jats:italic> = 0.032) were found to be independent factors for poor long-term outcome. Conventional immunosuppressive medications and\/or rituximab were prescribed, and in 83.3% of the patients, the kidney function improved. Repeat kidney biopsies confirmed the remission of interstitial inflammation in two patients under immunosuppressive therapy. However, the disease relapse rate was as high as 31.0%.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> We strongly recommend a kidney biopsy in active IgG4-RD, especially when there is proteinuria and renal dysfunction, because concurrent glomerular involvement and active interstitial inflammation should be assessed. A higher serum IgG1, IgG3, and ESR were independent factors for the poor long-term renal outcome; however, elevated IgG4 predicted a good renal prognosis, and appropriate and timely immunosuppressive therapy can help achieve a better prognosis.<\/jats:p>","DOI":"10.3389\/fmed.2021.736098","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T01:25:12Z","timestamp":1633569912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinicopathological Patterns and Predictors of the Functional Restoration of Immunoglobulin G4-Related Kidney Disease: A Chinese Single-Center Cohort Study"],"prefix":"10.3389","volume":"8","author":[{"given":"Tao","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ki.2013.393","article-title":"IgG4-related kidney disease","volume":"85","author":"Saeki","year":"2014","journal-title":"Kidney Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.2011010062","article-title":"Diagnosis of IgG4-related tubulointerstitial nephritis","volume":"22","author":"Raissian","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5851842","DOI":"10.1155\/2020\/5851842","article-title":"Urinary system manifestation of IgG4-related disease: Clinical, laboratory, radiological, and pathological spectra of a Chinese single-centre study","volume":"2020","author":"Teng","year":"2020","journal-title":"J Immunol Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/jcm8020258","article-title":"Kidney involvement in patients with Type 1 autoimmune pancreatitis","volume":"8","author":"Vujasinovic","year":"2019","journal-title":"J Clin Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol."},{"key":"B10","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury2012138\n            BombackA\n            BrowneT\n            CoppoR\n          10.1038\/kisup.2012.6.Kidney Int Suppl.22012"},{"key":"B11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3760\/cma.j.issn.0578-1426.2017.09.005","article-title":"The clinical characteristics of 346 patients with IgG4-related disease","volume":"56","author":"Panpan","year":"2017","journal-title":"Chin J Intern Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: Updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant."},{"key":"B14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: Dermatologic addendum to the 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"70","author":"Sunderk\u00f6tter","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859.2016","article-title":"Classification Criteria for primary Sj\u00f6gren's syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2016","journal-title":"Accept Publ Ann Rheum Dis Arthritis Rheum."},{"key":"B17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12882-020-01975-7","article-title":"Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: Case report and literature review","volume":"21","author":"Wang","year":"2020","journal-title":"BMC Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10157-015-1140-0","article-title":"Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction","volume":"20","author":"Saeki","year":"2016","journal-title":"Clin Exp Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","article-title":"IgG4-related disease: a clinical perspective","volume":"59","author":"Maritati","year":"2020","journal-title":"Rheumatology (Oxford)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10157-020-01993-7","article-title":"Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version","volume":"25","author":"Saeki","year":"2021","journal-title":"Clin Exp Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s10067-020-05484-8","article-title":"Prognostic factors in IgG4-related disease: A long-term monocentric Chinese cohort study","volume":"40","author":"Zongfei","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ajcp\/aqaa227","article-title":"Reactive eosinophil proliferations in tissue and the lymphocytic variant of hypereosinophilic syndrome","volume":"155","author":"King","year":"2021","journal-title":"Am J Clin Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/ndt\/gfr761","article-title":"Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: Distinction from non-IgG4-related tubulointerstitial nephritis","volume":"27","author":"Yoshita","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"F360","DOI":"10.1152\/ajprenal.00291.2018","article-title":"Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model","volume":"316","author":"Colon","year":"2019","journal-title":"Am J Physiol Ren Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology (Oxford)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"16483","DOI":"10.1038\/s41598-019-52847-6","article-title":"Different clinical patterns of IgG4-RD patients with and without eosinophilia","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pan.2019.11.016","article-title":"Significance of peripheral eosinophilia for diagnosis of IgG4-related disease in subjects with elevated serum IgG4 levels","volume":"20","author":"Mohapatra","year":"2020","journal-title":"Pancreatology."},{"key":"B28","unstructured":"Lymphadenopathy in IgG4-related disease: A phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker96775\n            TakanashiS\n            KikuchiJ\n            SasakiT\n            AkiyamaM\n            YasuokaH\n            YoshimotoK\n          10.1093\/rheumatology\/keaa64833167029Rheumatology (Oxford).602021"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e6707","DOI":"10.1097\/MD.0000000000006707","article-title":"Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis: A case report","volume":"96","author":"Su","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cca.2019.11.030","article-title":"An overlap of antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis and IgG4-related kidney disease","volume":"501","author":"Li","year":"2020","journal-title":"Clin Chim Acta."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e15303","DOI":"10.1097\/MD.0000000000015303","article-title":"Plasma exchange and rituximab treatments in primary membranous nephropathy combined with crescentic glomerulonephritis: A case report","volume":"98","author":"Lu","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"B32","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/0961203319840430","article-title":"A case with good response to Belimumab for lupus nephritis complicated by IgG4-related disease","volume":"28","author":"Yamamoto","year":"2019","journal-title":"Lupus."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1111\/1756-185X.13726","article-title":"Clinical and pathological features of patients with antineutrophil cytoplasmic antibody-associated vasculitides concomitant with IgG4-related disease","volume":"22","author":"Ma","year":"2019","journal-title":"Int J Rheum Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5414\/cnp74485","article-title":"Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms","volume":"74","author":"Palmisano","year":"2010","journal-title":"Clin Nephrol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ekir.2018.08.011","article-title":"Clinical manifestations and long-term outcomes of IgG4-related kidney and retroperitoneal involvement in a United Kingdom IgG4-related disease cohort","volume":"4","author":"Evans","year":"2019","journal-title":"Kidney Int Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1093\/rheumatology\/keab124","article-title":"What is the meaning of ANCA positivity in IgG4-related disease?","volume":"60","author":"Mart\u00edn-Nares","year":"2021","journal-title":"Rheumatology."},{"key":"B37","first-page":"279","article-title":"Antineutrophil cytoplasmic antibody and\/or antiglomerular basement membrane antibody associated crescentic glomerulonephritis in combination with IgG4-related tubulointerstitial nephritis","volume":"37","author":"Wang","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/gutjnl-2017-314548","article-title":"Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease","volume":"67","author":"Hubers","year":"2018","journal-title":"Gut."},{"key":"B39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/14397595.2018.1558519","article-title":"The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease?","volume":"29","author":"Umehara","year":"2019","journal-title":"Mod Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aaq0997","article-title":"Laminin 511 is a target antigen in autoimmune pancreatitis","volume":"10","author":"Shiokawa","year":"2018","journal-title":"Sci Transl Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0125331","DOI":"10.1371\/journal.pone.0125331","article-title":"Prohibitin is involved in patients with IgG4 related disease","volume":"10","author":"Du","year":"2015","journal-title":"PLoS ONE."},{"key":"B42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.humpath.2018.07.008","article-title":"Role of complement system in patients with biopsy-proven immunoglobulin G4\u2013related kidney disease","volume":"81","author":"Wang","year":"2018","journal-title":"Hum Pathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14397595.2019.1709942","article-title":"Hypocomplementemia is related to elevated serum levels of IgG subclasses other than IgG4 in IgG4-related kidney disease","volume":"31","author":"Fujisawa","year":"2021","journal-title":"Mod Rheumatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/art.41140","article-title":"Disease severity is linked to an increase in autoantibody diversity in IgG4-related disease","volume":"72","author":"Liu","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12882-021-02240-1","article-title":"Tertiary lymphoid tissue in early-stage IgG4-related tubulointerstitial nephritis incidentally detected with a tumor lesion of the ureteropelvic junction: A case report","volume":"22","author":"Miyanaga","year":"2021","journal-title":"BMC Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1111\/ajt.14758","article-title":"Recurrent IgG4-related tubulointerstitial nephritis concurrent with chronic active antibody mediated rejection: A case report","volume":"18","author":"Chibbar","year":"2018","journal-title":"Am J Transplant."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0183844","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.736098\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T01:25:18Z","timestamp":1633569918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.736098\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":47,"alternative-id":["10.3389\/fmed.2021.736098"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.736098","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"article-number":"736098"}}